MEKK NMN supplements NADH to reverse aging and delay aging.

With the rapid development of modern science and technology, many of the "Arabian Nights" that were once "fairies" have now become reality. SpaceX, owned by "Iron Man" Musk, has achieved vertical landing and recovery of heavy rockets, Tesla has achieved fully automatic unmanned driving, and Boston Dynamics has completed a humanoid robot that can fight autonomously. In the field of life sciences, NADH supplements, that is, enhanced products with NMN (β-nicotinamide mononucleotide) as the core ingredient, have appeared, and reversing aging and extending life has become a reality.

It is understood that MEKK, as an anti-aging product, uses advanced bio-enzyme catalysis technology to continuously renew and replace various aging and damaged tissue cells in the body, successfully simulating the enzyme-catalyzed synthesis of NMN in the human body, and has achieved the effects of improving sleep, delaying aging, enhancing immunity, and rejuvenating the body.

As early as the beginning of the 21st century, the laboratory of Professor David Sinclair of Harvard Medical School published the research results on NMN's anti-cellular aging, proposing that "supplementing NADH's precursor NMN can effectively delay or even reverse aging", opening the mysterious door to modern people's "immortality". In 2011, Professor Shinichiro Imai of the University of Washington and his research team obtained amazing therapeutic effects in the experiment of using NMN to treat diabetic mice, and reported the efficacy of NMN to the world for the first time. In 2013, Professor David Sinclair of Harvard Medical School found that with age, the level of cofactor coenzyme I (NADH) of longevity protein in the body continued to decline, leading to the decline of mitochondrial function of cell generators and triggering aging, and proposed the idea of ​​supplementing NMN to fight aging. Since 2014, hundreds of studies around the world have repeatedly proved that supplementing NMN can effectively increase and restore the level of coenzyme I in the body, significantly delay aging, and thus fundamentally improve various symptoms of aging based on the team's human and animal research results. In 2015, multiple brands of NMN products in the United States and Japan were launched on the market. After experiencing the miraculous effects of the product, the founding shareholders of the MEKK brand decided to set up a research team in California, USA, including dozens of experts in biological genes, genetics, nutrition and other fields, to develop high-purity, safe and reliable NMN products. In 2017, the research team formed by the founding shareholders of MEKK successfully prepared NMN products using the world's advanced bio-enzyme catalysis technology. After a series of rigorous scientific experiments, it was confirmed that taking NMN can delay aging, enhance immunity and has no side effects on the human body. In 2019, the research team successfully developed the world's first bio-enzyme catalysis technology to extract NMN, simulating the process of enzyme-catalyzed synthesis of NMN in the human body. In early 2020, "MEKK" was officially launched to the general public. This product uses β-NMN (only this type of NMN ingredient is biologically active) as the main raw material. It is an enteric-coated plant capsule developed using bio-enzyme catalysis technology. It can be stably present under gastric acid. Because NMN has a small molecular weight and decomposes quickly, the capsule can be quickly absorbed by the human body after reaching the small intestine, penetrate the cell wall directly to reach the mitochondria, repair the cell reorganization and regeneration function, and quickly activate SIRTUINS1-7 (commonly known as the longevity gene), slow down cell aging, and create systemic "rejuvenation" at the genetic level, returning to a young state from the inside out. In 2020, MEKK opened a flagship store on JD.com Tmall International for public sale. In 2021, MEKK has topped the JD.com sales list several times.

The biological and medical technologies related to reversing aging and extending life span now occupy a market of more than 100 billion US dollars, and are expected to become the next super outlet of the capital market in the next decade. In this context, MEKK can still stand out among many similar products, and its effectiveness is evident. Demographer Samuel Preston once wrote in his book that the key factor affecting life expectancy is technological innovation in the health field. The emergence of MEKK has provided hope for more people who love life. Reversing aging and extending life span has become a reality, and the intervention of cutting-edge biotechnology has become the mainstream way and trend for humans to fight aging.